Rockwell Medical Technologies (RMTI) Reports In-Line Q2 Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $8.08 -0.12%
Revenue Growth %: +14.9%
Financial Fact:
Selling, General and Administrative: 5.07M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: +14.9%
Financial Fact:
Selling, General and Administrative: 5.07M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Rockwell Medical Technologies (NASDAQ: RMTI) reported Q2 EPS of ($0.24), may not compare to the analyst estimate of ($0.13). Revenue for the quarter came in at $14.9 million versus the consensus estimate of $14.9 million.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- Neuronetics (STIM) Tops Q3 EPS by 7c
- Grainger (GWW) Tops Q3 EPS by 87c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
